Sinopharm Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	38,775	54,313	63,809	55,222	43,529	50,178
Short-Term Investments	-	3,172	3,330	3,199	2,812	2,633
Trading Asset Securities	0.14	0.16	0.55	0.5	11.75	39.14
Cash & Short-Term Investments	38,775	57,486	67,139	58,421	46,353	52,850
Cash Growth	-	-14.38%	14.92%	26.04%	-12.29%	27.68%
Accounts Receivable	251,635	201,479	185,790	171,204	172,576	146,049
Other Receivables	6,313	5,248	4,007	3,703	3,698	3,399
Receivables	257,948	206,727	189,797	174,908	176,273	149,448
Inventory	66,500	62,353	60,028	60,926	51,500	47,085
Restricted Cash	-	1,328	1,850	1,488	-	-
Other Current Assets	8,930	19,554	18,022	23,665	16,796	18,226
Total Current Assets	372,153	347,448	336,835	319,406	290,922	267,610
Property, Plant & Equipment	15,634	19,632	19,898	19,647	19,408	18,896
Long-Term Investments	10,878	10,894	10,551	9,840	9,184	8,473
Goodwill	6,203	6,252	7,186	7,156	7,199	7,287
Other Intangible Assets	3,999	2,473	2,830	2,941	3,116	3,361
Long-Term Accounts Receivable	-	1,156	793.92	1,123	874.58	870
Long-Term Deferred Tax Assets	2,903	2,408	1,964	1,980	1,787	1,602
Long-Term Deferred Charges	1,180	224.01	180.02	74.44	76.61	81.26
Other Long-Term Assets	5,432	2,344	3,158	2,607	2,845	3,057
Total Assets	418,382	392,831	383,395	364,775	335,412	311,237
Accounts Payable	157,062	151,109	146,632	137,085	128,431	112,632
Accrued Expenses	1,795	8,123	8,832	9,571	8,354	7,760
Current Portion of Long-Term Debt	-	62,729	54,730	52,997	55,152	54,959
Current Portion of Leases	-	1,761	1,797	1,636	1,548	1,406
Current Income Taxes Payable	2,335	1,447	1,775	1,703	1,614	1,470
Current Unearned Revenue	7,029	6,829	6,399	10,396	6,086	7,324
Other Current Liabilities	31,364	18,377	21,326	21,574	18,122	18,426
Total Current Liabilities	276,196	250,376	241,491	234,963	219,307	203,977
Long-Term Debt	3,820	8,637	13,834	11,750	8,419	8,919
Long-Term Leases	2,841	3,259	3,421	3,207	3,250	3,243
Long-Term Unearned Revenue	348.03	413.86	448.24	493.85	462.74	453.87
Pension & Post-Retirement Benefits	94.06	412.88	366.51	380.71	387.7	396.42
Long-Term Deferred Tax Liabilities	682.58	638.75	788.38	936.74	1,023	1,112
Other Long-Term Liabilities	2,227	2,406	2,727	2,975	2,910	3,189
Total Liabilities	286,208	266,144	263,076	254,706	235,758	221,289
Common Stock	3,121	3,121	3,121	3,121	3,121	3,121
Additional Paid-In Capital	20,459	24,641	24,641	24,641	24,641	24,641
Retained Earnings	58,640	55,532	51,197	44,701	38,516	32,908
Treasury Stock	-3.84	-3.84	-3.84	-3.84	-3.84	-3.84
Comprehensive Income & Other	34.4	-4,407	-4,373	-4,391	-4,388	-4,308
Total Common Equity	82,251	78,884	74,582	68,069	61,886	56,359
Minority Interest	49,923	47,804	45,737	42,001	37,768	33,588
Shareholders' Equity	132,174	126,687	120,319	110,069	99,654	89,947
Total Liabilities & Equity	418,382	392,831	383,395	364,775	335,412	311,237
Total Debt	83,271	76,386	73,782	69,590	68,368	68,527
Net Cash (Debt)	-44,496	-18,900	-6,643	-11,169	-22,016	-15,677
Net Cash Per Share	-14.27	-6.06	-2.13	-3.58	-7.05	-5.04
Filing Date Shares Outstanding	3,121	3,121	3,121	3,121	3,121	3,121
Total Common Shares Outstanding	3,121	3,121	3,121	3,121	3,121	3,121
Working Capital	95,957	97,072	95,344	84,443	71,616	63,633
Book Value Per Share	26.36	25.28	23.90	21.81	19.83	18.06
Tangible Book Value	72,049	70,159	64,566	57,972	51,571	45,711
Tangible Book Value Per Share	23.09	22.48	20.69	18.58	16.53	14.65
Buildings	-	13,752	12,997	12,907	12,127	11,346
Machinery	-	10,728	10,099	9,169	8,412	7,605
Construction In Progress	-	739.81	505.47	800.05	718.53	519.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.